Cardiac rhythm devices in heart failure with reduced ejection fraction - role, timing, and optimal use in contemporary practice. European Journal of Heart Failure expert consensus document
Bozkurt, Biykem (Baylor College of Medicine (Houston, Estats Units d'Amèrica))
Mullens, Wilfried (Hasselt University)
Leclercq, Christophe (University of Rennes)
Russo, Andrea M. (Cooper Medical School of Rowan University)
Savarese, Gianluigi (Karolinska Institutet (Estocolm, Suècia))
Böhm, Michael (Saarland University)
Hill, Loreena (Queen's University of Belfast)
Kinugawa, Koichiro (University of Toyama)
Sato, Naoki (Kawaguchi Cardiovascular and Respiratory Hospital)
Abraham, William T. (Ohio State University School of Medicine)
Bayés-Genís, Antoni (Universitat Autònoma de Barcelona)
Mebazaa, Alexandre (Université Paris Cité)
Rosano, Giuseppe M.C. (University of London)
Zieroth, Shelley (University of Manitoba (Winnipe, Canadà))
Linde, Cecilia (Karolinska Institutet (Estocolm, Suècia))
Butler, Javed (University of Mississippi)

Data:	2025
Resum:	Guidelines for management of heart failure with reduced ejection fraction (HFrEF) emphasize personalized care, patient engagement, and shared decision-making. Medications and cardiac rhythm management (CRM) devices are recommended with a high level of evidence. However, there are significant disparities: patients who could benefit from devices are frequently referred too late or not at all. Misconceptions about device therapy and the notion that the needs of patients (especially the prevention of sudden cardiac death) can now be met by expanding drug therapies may play a role in these disparities. This state-of-the-art review is produced by members of the DIRECT HF initiative, a patient-centred, expert-led educational programme that aims to advance guideline-directed use of CRM devices in patients with HFrEF. This review discusses the latest evidence on the role of CRM devices in reducing HFrEF mortality and morbidity, and provides practical guidance on patient referral, device selection, implant timing and patient-centred follow-up.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Patient-centred heart failure care ; Sudden cardiac death ; Cardiac dyssynchrony ; Cardiac implantable electronic device ; Implantable cardioverter-defibrillator ; Cardiac resynchronization therapy
Publicat a:	European Journal of Heart Failure, Vol. 27 (april 2025) , p. 1242-1261, ISSN 1879-0844

DOI: 10.1002/ejhf.3641
PMID: 40204670

20 p, 2.2 MB

El registre apareix a les col·leccions:
Articles > Articles de recerca
Articles > Articles publicats